Kevin Perez @kgiperez

Computational biology and aging usi.to/bm9u Bellinzona, Switzerland Joined December 2012

Tweets

260
Followers

567
Following

585
Likes

422

Kevin Perez @kgiperez

2 weeks ago

Link to the study. nature.com/articles/s4158…

0 0 0 58 0

View Details

Results are mixed, "the chronological clock detected detrimental interventions but did not robustly capture lifespan extension. [...] By contrast, normalized-age and especially mortality clocks distinguished both short-lived and long-lived models". 3/3

1 0 0 89 0

View Details

Kevin Perez @kgiperez

2 weeks ago

Buried deep in this study is an answer to one of the most important questions in the field. Can we use clocks to predict which interventions can extend lifespan? Turns out: it depends which clock you use. 1/3

1 1 4 680 2

View Details

Kevin Perez @kgiperez

a month ago

Our new paper is out in Cell Reports! We built a cross-species lifespan-screening platform spanning yeast, worms, flies, killifish, and mice, testing 400+ compounds across thousands of conditions to identify geroprotectors and conserved pathways. Paper: cell.com/cell-reports/f…

1 9 21 2K 4

View Details

David Sinclair @davidasinclair

a year ago

NEW STUDY: Ocampo Lab publishes reprogramming cocktails that reduce DNA damage & extend lifespan of worms up to 42%. The race is on to test them in humans 🚀

55 109 965 97K 293

View Details

Ocampo Lab @OcampoLab

a year ago

Excited to share our new publication! We previously showed that age reversal can be achieved using transcription factor-based reprogramming. Now, we demonstrate that it can also be done with chemical cocktails to achieve lifespan extension! embopress.org/doi/full/10.10…

2 27 92 9K 25

View Details

Kevin Perez @kgiperez

a year ago

One of the most promising ways to tackle aging!

Sierra Lore @Sierra_Lore_

a year ago

What if the path to slowing aging wasn’t a drug, but replacing worn out parts? Our new paper out today in @NatureAging shows how this could one day work. We map a unified framework—from scaffolds & bioprinted tissues to pacemakers, xenotransplants & brain machine interfaces—for

21 80 244 61K 138

0 2 16 982 1

View Details

Bryan Johnson @bryan_johnson

2 years ago

0/ It sounds wild, but low-dose Cialis (tadalafil) and Viagra (sildenafil) are both drawing attention for longevity benefits. Recent clinical evidence indicates the use of either correlates to longer survival in men, in addition to their potential for heart health, metabolism, and even brain function. A new retrospective study evaluated the longevity potential of 407 prescription drugs in over 200,000 participants, with both Cialis and Viagra being among the surprising promising hits in men (yet to be evaluated in women, since the retrospective studies only cover existing drug use for established indications). Sildenafil will soon be tested in the NIA’s ITP, the most credible pre-clinical longevity drug testing program in mice.

30 16 650 363K 407

View Details

Kevin Perez @kgiperez

2 years ago

Two new papers from our group published in @AgingCell today 🎉! Aging clocks in dogs onlinelibrary.wiley.com/doi/full/10.11… Lifespan-extending drugs in worms onlinelibrary.wiley.com/doi/full/10.11…

3 1 34 2K 11

View Details

Kevin Perez @kgiperez

2 years ago

Announcements about open positions to come soon! Please reach out to me directly for collaborations.

0 0 1 111 0

View Details

Kevin Perez @kgiperez

2 years ago

We leverage public biobanks to identify drugs associated with lower all-cause mortality in the general population, and validate their effects on lifespan and healthspan in model organisms (e.g., worms, flies or mice).

1 0 0 126 0

View Details

Kevin Perez @kgiperez

2 years ago

Happy to share that I’ve started a new position as Junior Group Leader @ChariteBerlin ! Our aging research group is interested in identifying therapeutics to extend lifespan, prevent age-related diseases and frailty in humans. expendo.charite.de/en/group_kevin…

1 0 12 509 2

View Details

Victoria Forest @victoriafores

2 years ago

@ZelarCity's final summit is this weekend and I’m incredibly proud and in awe of what we've co-created over these 6 weeks. We’re bringing together some of the brightest minds pushing the boundaries of what's possible in longevity and we’re thrilled to announce that @geochurch, a true pioneer in genetics and synthetic biology, will be sharing his insights. This is a rare opportunity to hear directly from one of the leading visionaries in the field. Don’t miss it. Sign up here 👇 lnkd.in/dZWTCTsh A big shout-out to my incredible team for their hard work and dedication: @longevion @strygah @EliasSchlie @ElenaMishina15 @ZivaPecjak and everyone contributing. You rock!

2 4 18 1K 1

View Details

Kevin Perez @kgiperez

2 years ago

Our manuscript on the association between prescription medications and all-cause mortality in the UK population was just published in @AgingCell ! onlinelibrary.wiley.com/doi/10.1111/ac… See thread 👇

Kevin Perez @kgiperez

3 years ago

Happy to share the first manuscript coming out of @epiterna_ ! In this work we examine the association between more than 400 commonly prescribed medications and all-cause mortality risk in half a million participants of the UK Biobank. medrxiv.org/content/10.110…

6 21 96 33K 45

2 2 11 2K 3

View Details

Kevin Perez @kgiperez

2 years ago

We thank all the team members at @epiterna_, especially Grace Phelps who led this study!

0 0 1 221 0

View Details

Kevin Perez @kgiperez

2 years ago

Lastly, in a small proof-of-concept screening of ~200 molecules, we identified new compounds extending lifespan in C. elegans, including safinamide and fenbendazole.

1 0 2 501 0

View Details

Kevin Perez @kgiperez

2 years ago

Glad to share our second manuscript coming out of @epiterna_! biorxiv.org/content/10.110… In this study, we evaluated some of the most commonly reported lifespan-extending molecules in C. elegans, examining their effects on lifespan with different diets, strains, and starting age. By performing combinatorial testing, we identified combinations of molecules with synergistic effect and dramatic lifespan extension. Lastly, we performed a small proof-of-concept screen with more than 200 molecules, and identified novel lifespan extending drugs in C. elegans.